217 related articles for article (PubMed ID: 25623430)
1. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
3. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
[TBL] [Abstract][Full Text] [Related]
4. [Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
Núñez J; Sanchis J; Núñez E; Fonarow GC; Bodí V; Bertomeu-González V; Miñana G; Palau P; Fácila L; Chorro FJ; Bertomeu-Martínez V; Llàcer A
Rev Esp Cardiol; 2011 Dec; 64(12):1100-8. PubMed ID: 21958731
[TBL] [Abstract][Full Text] [Related]
5. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction.
de la Espriella R; Núñez E; Llàcer P; García-Blas S; Ventura S; Núñez JM; Sánchez R; Fácila L; Vaquer JM; Bodí V; Santas E; Miñana G; Mollar A; Núñez G; Chorro FJ; Górriz JL; Sanchis J; Bayés-Genis A; Núñez J
Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):616-623. PubMed ID: 32624444
[TBL] [Abstract][Full Text] [Related]
6. Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry.
Oh J; Kang SM; Hong N; Youn JC; Han S; Jeon ES; Cho MC; Kim JJ; Yoo BS; Chae SC; Oh BH; Choi DJ; Lee MM; Ryu KH
Int J Cardiol; 2013 Oct; 168(5):4739-43. PubMed ID: 23958420
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment.
Llàcer P; Bayés-Genís A; Núñez J
Med Clin (Barc); 2019 Apr; 152(7):266-273. PubMed ID: 30442374
[TBL] [Abstract][Full Text] [Related]
8. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
[TBL] [Abstract][Full Text] [Related]
11. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
12. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
[TBL] [Abstract][Full Text] [Related]
13. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
[TBL] [Abstract][Full Text] [Related]
14. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
15. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
[TBL] [Abstract][Full Text] [Related]
16. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study.
van Deursen VM; Edwards C; Cotter G; Davison BA; Damman K; Teerlink JR; Metra M; Felker GM; Ponikowski P; Unemori E; Severin T; Voors AA
J Card Fail; 2014 Jun; 20(6):407-13. PubMed ID: 24642379
[TBL] [Abstract][Full Text] [Related]
17. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
18. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
20. Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.
Whellan DJ; Stebbins A; Hernandez AF; Ezekowitz JA; McMurray JJ; Mather PJ; Hasselblad V; O'Connor CM
J Card Fail; 2016 Jun; 22(6):409-16. PubMed ID: 26952241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
